K

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Biologics Process Development Senior Director - Process Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeLexington, MA, USA$240k - $277kHybrid

About the Job

Requirements

  • A Ph.D. in Chemical Engineering, Bioengineering, Biochemistry, or a related scientific discipline with 10 or more years of industry experience, or an M.S. or B.S. with 14 or more years of relevant biopharmaceutical experience.
  • At least five years of experience successfully managing and developing technical teams of scientists and engineers in a biopharmaceutical setting.
  • Deep technical background running bioreactors in a process development setting.
  • Experience establishing production processes for biologics in cGMP manufacturing settings.
  • Experience throughout the biopharmaceutical product life cycle, including process characterization studies, in-process control strategy, and process validation, is preferred but not required.

Responsibilities

  • Provide strategic and operational leadership for the Process Development group, with a specialized focus on complex biologics utilizing CHO cell culture platforms.
  • Oversee planning, execution, resource allocation, and project delivery as Process Development department head.
  • Manage, mentor, and facilitate development of staff in Upstream and Downstream Process Development.
  • Provide subject matter expertise in CHO cell culture development, including media optimization, feeding strategies, and cell line evaluation for complex biologics such as bispecifics, fusion proteins, and heavily glycosylated proteins.
  • Oversee upstream bioreactor operations from bench-top to pilot scale, applying experience in bioreactor design, scale-up dynamics, and process characterization within process development.
  • Drive innovation and process technology development to increase efficiency and purity.
  • Maintain working knowledge of downstream purification technologies for integrated end-to-end process development.
  • Oversee process development studies, data review, and comprehensive documentation according to laboratory procedures and data integrity standards.
  • Facilitate early program transitions from Research to Development, ensuring processes are scalable and suitable for development.
  • Coordinate with internal Quality, Manufacturing, Analytical Development, Program Management, Research, and non-Clinical (Tox) teams.
  • Assure cGMP success through effective technology transfer and support of cGMP manufacturing; coordinate with Manufacturing to achieve program success.
  • Lead technology transfer to CDMOs and mentor team members to support transfers.
  • Identify efficiency opportunities, coordinate with groups, and ensure harmonized implementation of best practices.

Desired Qualifications

  • Management experience must include managing a team of at least five.
  • Experience reviewing or authoring CMC sections for regulatory submissions.
  • Demonstrated ability to work cross-functionally to achieve goals.
  • Knowledge of upstream and downstream process development for biologics.
  • Ability to multitask and successfully execute multiple parallel programs.
  • Knowledge of cGMP and manufacturing operations.
  • Knowledge of technology transfer.
  • Knowledge of good laboratory practices, including hands-on implementation.
  • Knowledge of regulatory guidelines, particularly those for IND filing.

About the Company

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.

Company size
51-200
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Keros Therapeutics

See more jobs